Irbm-Merck working on a new anti-Covid aerosol drug
(ANSA) – ROME, NOV 29 – The biotechnology company Irbm of Pomezia is working in collaboration with the pharmaceutical company Merck for the development of
(ANSA) – ROME, NOV 29 – The biotechnology company Irbm of Pomezia is working in collaboration with the pharmaceutical company Merck for the development of
(ANSA) – ANCONA, 26 NOV – After obtaining the favorable opinion of the Ethics Committee on the presence of the 4 requirements for access to
(ANSA) – ROME, NOVEMBER 25 – The situation of the fight against HIV in the world is improving, with an increasing number of patients in
(ANSA) – ROME, NOVEMBER 24 – Not just antibiotics. Bacteria are capable of developing resistance mechanisms against other drugs as well. A study conducted by
(ANSA) – ROME, NOVEMBER 22 – Almost 20% of hypertensive people take other medicines, in addition to those for blood pressure, which have the side
(ANSA) – PARIS, NOV 20 – Several collaborators of the Marseille professor Didier Raoult, who in the first period of the pandemic had become the
(ANSA) – ROME, NOV 17 – A research by the Institute of Materials Workshop of the National Research Council of Trieste (Cnr-Iom), in collaboration with
(ANSA) – ANCONA, NOV 15 – “Dear patient, Covid has devastated human and professional life. Up to now, the vaccine is the only weapon to
(ANSA) – TRIESTE, 15 NOV – The arrears of compensation for people who have suffered malformations caused by taking the drug thalidomide have been equalized
“Dear patient, Covid has devastated human and professional life. Up to now, the vaccine is the only weapon to avoid getting sick. If you have